Cutler Group’s Lucira Health, Inc. Common Stock LHDX Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2021
Q4
– Sell
-1,700
Closed -$3K – 6421
2021
Q3
$3K Buy
+1,700
New +$14.3K ﹤0.01% 4921

Other funds holding LHDX

Cutler Group's LHDX Position: Q3 2022 in Review

Cutler Group sold out of Lucira Health, Inc. Common Stock (LHDX) in Q3 2022, closing a stake of 3,515 shares — an estimated $6K sold.

Cutler Group first reported a position in LHDX in Q3 2021 and held it in 4 quarters. The position peaked at $243K in Q4 2021. 28 funds tracked by Wall St. Rank hold LHDX as of Q3 2022.

  • Cutler Group reported no remaining Lucira Health, Inc. Common Stock position as of Q3 2022 after selling out during the quarter.
  • Cutler Group sold 3,515 Lucira Health, Inc. Common Stock shares in Q3 2022, an estimated $6K.
  • Cutler Group first reported a position in Lucira Health, Inc. Common Stock in Q3 2021 and held it in 4 quarters.
  • Cutler Group's Lucira Health, Inc. Common Stock position peaked at $243K in Q4 2021.
  • 28 funds tracked by Wall St. Rank held Lucira Health, Inc. Common Stock as of Q3 2022.

Based on Cutler Group's 13F filing for Q3 2022, filed 25 Oct 2022.